Confluence Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Sell |
39,857
-2,865
| -7% | -$214K | 0.04% | 146 |
|
|
2025
Q1 | $2.71M | Buy |
+42,722
| New | +$2.71M | 0.04% | 159 |
|
|
2017
Q3 | – | Sell |
-54,092
| Closed | -$2.14M | – | 243 |
|
|
2017
Q2 | $2.14M | Sell |
54,092
-861
| -2% | -$34K | 0.04% | 181 |
|
|
2017
Q1 | $2.23M | Sell |
54,953
-594
| -1% | -$24.1K | 0.05% | 176 |
|
|
2016
Q4 | $2.23M | Sell |
55,547
-643
| -1% | -$25.8K | 0.05% | 177 |
|
|
2016
Q3 | $2.04M | Buy |
56,190
+230
| +0.4% | +$8.33K | 0.05% | 176 |
|
|
2016
Q2 | $1.62M | Sell |
55,960
-1,054
| -2% | -$30.6K | 0.04% | 183 |
|
|
2016
Q1 | $1.99M | Buy |
57,014
+2,877
| +5% | +$101K | 0.06% | 167 |
|
|
2015
Q4 | $1.75M | Buy |
54,137
+1,074
| +2% | +$34.6K | 0.06% | 176 |
|
|
2015
Q3 | $1.72M | Buy |
53,063
+4,190
| +9% | +$135K | 0.06% | 175 |
|
|
2015
Q2 | $2.02M | Buy |
48,873
+628
| +1% | +$26K | 0.07% | 163 |
|
|
2015
Q1 | $2.17M | Buy |
48,245
+949
| +2% | +$42.6K | 0.08% | 159 |
|
|
2014
Q4 | $1.77M | Buy |
47,296
+59
| +0.1% | +$2.21K | 0.07% | 163 |
|
|
2014
Q3 | $1.65M | Buy |
47,237
+616
| +1% | +$21.5K | 0.07% | 170 |
|
|
2014
Q2 | $1.65M | Buy |
46,621
+669
| +1% | +$23.6K | 0.08% | 170 |
|
|
2014
Q1 | $1.5M | Buy |
45,952
+14,165
| +45% | +$462K | 0.08% | 170 |
|
|
2013
Q4 | $1.34M | Buy |
31,787
+1,621
| +5% | +$68.3K | 0.07% | 174 |
|
|
2013
Q3 | $1.2M | Buy |
30,166
+553
| +2% | +$22.1K | 0.07% | 179 |
|
|
2013
Q2 | $1.22M | Buy |
+29,613
| New | +$1.22M | 0.08% | 168 |
|